Skip to Content

How does Dexycu work to treat inflammation associated with cataract surgery?

Answers (1)

Official Answer by 7 Mar 2018

Dexycu (dexamethasone) from Icon Bioscience Inc., is an injectable, long-acting, corticosteroid intraocular suspension administered into the posterior (rear) chamber of the eye to lower inflammation (swelling) after cataract surgery. Dexycu is given as a single injection at the conclusion of surgery. Dexamethasone is a corticosteroid that prevents the release of substances in the body that cause inflammation.

What is the advantage of Dexycu injection over eye drops?

Because Dexycu is given as a single, long-acting injection after cataract surgery, patients would not need to self-administer anti-inflammatory eye drops several times daily over a period of weeks after eye surgery. This may be especially advantageous in older patients, and lower the risk of non-compliance and dosing errors linked with frequent eye drops following cataract surgery. However, other eye drops, such as antibiotics, may be needed after cataract surgery. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 15 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 12 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 12 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 11 days ago 1 answerFAQ by